Synonym: N-[4-Methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2´-methyl-4´-(5-methyl-1,2,4-oxadiazol-3-yl)-1,1´-biphenyl-4-carboxamide hydrochloride hydrate
CAS Number: 148642-42-6 (anhydrous)
Empirical Formula (Hill Notation): C29H31N5O3 · HCl · xH2O
Molecular Weight: 534.05 (anhydrous basis)
MDL Number: MFCD11045922
Linear Formula: C29H31N5O3 · HCl · xH2O
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts G5793-10MG.
| assay |
>98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C29H31N5O3.ClH.H2O/c1-19-17-23(28-30-20(2)37-32-28)9-11-25(19)21-5-7-22(8-6-21)29(35)31-24-10-12-27(36-4)26(18-24)34-15-13-33(3)14-16-34;;/h5-12,17-18H,13-16H2,1-4H3,(H,31,35);1H;1H2 |
| InChI key |
KSXUSAQPMSACQS-UHFFFAOYSA-N |
| originator |
GlaxoSmithKline |
| Quality Level |
100  |
| SMILES string |
O.Cl.COc1ccc(NC(=O)c2ccc(cc2)-c3ccc(cc3C)-c4noc(C)n4)cc1N5CCN(C)CC5 |
| solubility |
DMSO: 10 mg/mL, clear |
| storage condition |
desiccated |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Potent, selective and orally active 5-HT1B/1D serotonin receptor antagonist. |
| Disclaimer: |
Desiccate |
| Features and Benefits: |
This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Legal Information: |
Sold for research purposes under agreement from GlaxoSmithKline |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
>98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |